We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Expedeon AG Announces Commercial-Use Licence of Proprietary Technology in Diagnostic Assay

Product News   Sep 14, 2018

 
Expedeon AG Announces Commercial-Use Licence of Proprietary Technology in Diagnostic Assay

Credit: Expedeon

 
 
FURTHER INFORMATION
 
 
 

Related Product News

Shuwen Biotech‘s PD-L1 Detection Kit Validated in Clinical Trials of Leading Drugs

Product News

Patients with advanced esophageal squamous cell carcinoma with higher PD-L1 expression can benefit better from leading PD-1 antibody drugs.

READ MORE


New Maetrics Whitepaper Highlights the Compliance Changes to Clinical Evaluation Reports

Product News

Whitepaper reviews the compliance changes to CERs in light of the new EU Medical Device Regulations and how to navigate them.

READ MORE

Like what you just read? You can find similar content on the communities below.

Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE